AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
February 02 2016 - 08:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that
company management will discuss AMAG’s business and financial
outlook, strategy and growth prospects at the following investor
conferences taking place in February 2016.
- LEERINK Partners 5th Annual Global Healthcare
ConferencePresentation: Wednesday, February 10, 2016
at 8:00 a.m. ET*One-on-one meetings: Wednesday, February 10,
2016Location: New York, NY
- RBC Capital Markets Healthcare Conference 2016
Presentation: Wednesday, February 24, 2016
at 8:30 a.m. ET*One-on-one meetings: Wednesday, February 24,
2016Location: New York, NY
*A live webcast of the presentation will be accessible through
the Investors section of the company’s website
at www.amagpharma.com, and will be archived for 30
days.
About AMAG
AMAG Pharmaceuticals uses its business and clinical expertise to
develop and commercialize products that provide clear benefits and
improve people’s lives. Based in Waltham, MA, AMAG has a diverse
portfolio of products in the areas of maternal health, anemia
management and cancer supportive care. AMAG continues to work to
expand the impact of these and future products for patients by
delivering on its growth strategy, which includes organic growth,
as well as the pursuit of products and companies that align with
AMAG’s existing therapeutic areas or those that could benefit from
its proven core competencies. For additional company information,
please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG
Pharmaceuticals, Inc.
AMAG Pharmaceuticals Contact:
Maryann Cimino
Manager, Corporate Communications & External Affairs
617-498-3375
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Feb 2024 to Mar 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Mar 2023 to Mar 2024